CLDI logo

Calidi Biotherapeutics (CLDI) EBIT

Annual EBIT

-$28.13 M
-$2.87 M-11.37%

December 31, 2023


Summary


Performance

CLDI EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

Quarterly EBIT

-$4.84 M
+$648.00 K+11.81%

September 30, 2024


Summary


Performance

CLDI Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

TTM EBIT

-$25.30 M
-$3.15 M-14.21%

September 30, 2024


Summary


Performance

CLDI TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLDIprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CLDI EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.4%-186.4%+8.9%
3 y3 years-262.1%-186.4%+8.9%
5 y5 years-262.1%-186.4%+8.9%

CLDI EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-172.9%at low-186.4%+60.3%-639.0%+19.5%
5 y5-year-262.1%at low-186.4%+60.3%-639.0%+19.5%
alltimeall time-262.1%at low-186.4%+60.3%-639.0%+19.5%

Calidi Biotherapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.84 M(-11.8%)
-$25.30 M(+14.2%)
Jun 2024
-
-$5.49 M(-21.3%)
-$22.15 M(-23.2%)
Mar 2024
-
-$6.97 M(-13.0%)
-$28.86 M(+2.6%)
Dec 2023
-$28.13 M
-$8.01 M(+374.2%)
-$28.13 M(+1.3%)
Sep 2023
-
-$1.69 M(-86.1%)
-$27.78 M(-11.6%)
Jun 2023
-
-$12.19 M(+95.3%)
-$31.42 M(+63.4%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$6.24 M(-18.5%)
-$19.23 M(+48.1%)
Dec 2022
-$25.26 M(+145.0%)
-
-
Dec 2022
-
-$7.66 M(+43.9%)
-$12.99 M(+48.4%)
Sep 2022
-
-$5.33 M(+55.5%)
-$8.75 M(+155.5%)
Dec 2021
-$10.31 M(+32.7%)
-$3.42 M
-$3.42 M
Dec 2020
-$7.77 M
-
-

FAQ

  • What is Calidi Biotherapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics annual EBIT year-on-year change?
  • What is Calidi Biotherapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics quarterly EBIT year-on-year change?
  • What is Calidi Biotherapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Calidi Biotherapeutics?
  • What is Calidi Biotherapeutics TTM EBIT year-on-year change?

What is Calidi Biotherapeutics annual earnings before interest & taxes?

The current annual EBIT of CLDI is -$28.13 M

What is the all time high annual EBIT for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high annual earnings before interest & taxes is -$7.77 M

What is Calidi Biotherapeutics annual EBIT year-on-year change?

Over the past year, CLDI annual earnings before interest & taxes has changed by -$2.87 M (-11.37%)

What is Calidi Biotherapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of CLDI is -$4.84 M

What is the all time high quarterly EBIT for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high quarterly earnings before interest & taxes is -$1.69 M

What is Calidi Biotherapeutics quarterly EBIT year-on-year change?

Over the past year, CLDI quarterly earnings before interest & taxes has changed by -$3.15 M (-186.44%)

What is Calidi Biotherapeutics TTM earnings before interest & taxes?

The current TTM EBIT of CLDI is -$25.30 M

What is the all time high TTM EBIT for Calidi Biotherapeutics?

Calidi Biotherapeutics all-time high TTM earnings before interest & taxes is -$3.42 M

What is Calidi Biotherapeutics TTM EBIT year-on-year change?

Over the past year, CLDI TTM earnings before interest & taxes has changed by +$2.48 M (+8.93%)